MEDICA LABMED FORUM

Agenda 12 November 2018

10:30 h – 10:45 h
Hot topics in infectious diseases
PD Dr. med. Beniam Ghebremedhin
Universität Witten / Herdecke, HELIOS Universitätsklinikum Wuppertal

10:45 h – 11:15 h
The human microbiome - diagnostic and therapeutic aspects
Prof. Dr. med. André Gessner
Institut für Mikrobiologie und Hygiene, Universitätsklinikum Regensburg

11:15 h – 11:40 h
Practical applications of microbiome and biofilm analyses in parodontitis patients
Dr. med. Rudolf Raßhofer
MVZ Karlsplatz, München

11:40 h – 12:05 h
Novel molecular identification tools for gram-positive bacteria
Dr. rer. nat. Franziska Layer
Robert-Koch-Institut, Wernigerode

12:05 h – 12:25 h
Novel molecular identification tools for gram-negative bacteria
Dr. rer. nat. Yvonne Pfeifer
Robert-Koch-Institut, Wernigerode

12:25 h – 13:00 h
Ion mobility spectrometry – a new tool for rapid microbial detection
Dr. rer. nat. Wolfang Vautz
ION-GAS GmbH, Dortmund

14:00 h – 15:20 h
Round-table discussion
Ghebremedhin, Gessner, Raßhofer, Layer, Pfeifer, Vautz


[Version: 09 November 2018, subject to changes]

Agenda 13 November 2018

10:30 h – 11:00 h
Analytical challenges for continous glucose monitoring
Prof. Dr. med. Peter Luppa
Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar der TU München

11:00 h – 11:30 h
Promises of continuous glucose monitoring and electronic data transfer in regional diabetes care
Dr. Timo Kouri
MD, HUSLAB, Department of Clinical Chemistry and Haematology, Helsinki University

11:30 h – 12:00 h
High performance sports and point-of-care testing
Prof. Dr. Billy Sperlich
Head of Integrative & Experimental Exercise Science & Training, Julius-Maximilians-University Würzburg

12:00 h – 12:30 h
Point-of-care testing and eLearning
Dr. med Joachim Lehner
Chirurgische Intensivmedizin, Klinikum Dortmund

12:30 h – 13:00 h
Emerging technologies in point-of-care testing
Prof. Dr. rer. nat. Oliver Hayden
Heinz-Nixdorf-Chair of Biomedical Electronics, TranslaTUM, TU München


Indutry Slots

13:00 h – 13:20 h
Diagnostic labs & technology: the next 10 years
What does the future hold for diagnostic labs, between utter ruin and unprecedented prosperity.
Dr. Al Hakim, Medicus Al GmbH

13:20 h – 13:40 h
How Disc Pump is enabling innovation in Point-Of-Care (POC) diagnostics
John Watson, TTP Ventus

13:40 h – 14:00 h
(tba)
Dr. Mark Eccleston, Belgian Volition


14:00 h – 15:20 h
Round-table discussion
Luppa, Kouri, Lehner, Hayden, Sperlich


Industry slots

15:20 h – 15:40 h
Laboratrory technologies (tba)
Gregor Fornol, Central BioHub GmbH


[Version: 09 November 2018, subject to changes]

Agenda 14 November 2018

10:30 h – 10:45 h
Hot topics in cardiology
Prof. Dr. med. Stefan Holdenrieder
Deutsches Herzzentrum München und Universität Bonn

10:45 h – 11:30 h
Established and new markers fo cardiac risk assessment
Prof. Dr. med. Karl Lackner
Institut für Klinische Chemie und Laboratoriumsmedizin, Universitätsmedizin Mainz

11:30 h – 12:00 h
Oxidative stress: a biomarker opportunity in cardiology?
Prof. Dr. med. Agnes Görlach
Deutsches Herzzentrum München

12:00 h – 12:30 h
New insights into heart insufficiency in newborns and children
PD Dr. med. Oktay Tutarel
Deutsches Herzzentrum München

12:30 h – 13:00 h
Nucleic acid-based diagnostic approaches in cardiology
Prof. Dr. med. Stefan Holdenrieder
Deutsches Herzzentrum München und Universität Bonn

14:00 h – 15:20 h
Round-table discussion
Holdenrieder, Lackner, Görlach, Tutarel


[Version: 11 November 2018, subject to changes]

Agenda 15 November 2018

10:30 h - 10:45 h
Opening remarks
Prof. Dr. med. Stefan Holdenrieder, Deutsches Herzzentrum München und Universität Bonn
Dr. rer. nat. Peter Quick, Promega GmbH, Mannheim
Dr. med. Ronald Biemann, Institut für Klinische Chemie und Pathobiochemie, Universität Magdeburg

10:45 h - 11:00 h
Adipositas research
Dr. med. Ronald Biemann
Institut für Klinische Chemie und Pathobiochemie, Universität Magdeburg

11:00 h - 11:15 h
Liquid biopsy
Dr. rer. nat. Dr. med. Christof Winter
Institut für Klinische Chemie und Pathobiochemie, TU München

11:15 h - 11:30 h
Machine learning in epigenomics
Dr. med. Alexander Tolios
Universitätsklinik für Blutgruppenserologie und Transfusionsmedizin, Wien

11:30 h - 11:45 h
Nucleic acid sensing after immunotherapy
Silke Lambing
Institut für Klinische Chemie und Klinische Pharmakologie, Universitätsklinikum Bonn

11:45 h - 12:00 h
Nucleic acid biomarkers
Dr. rer. nat. Abel  Bronkhorst
Deutsches Herzzentrum, München

12:00 h - 12:15 h
Metabolome analytics by LCMS
Dr. rer. nat. Alexander Rupp
Deutsches Herzzentrum, München

12:15 h - 12:30 h
High-quality biobanking as a powerful resource
Dr. rer. nat. Lena Figge
Interdisziplinäres Centrum für Biobanking-Lübeck (ICB-L)

12:30 h – 12:45 h
Diagnostic importance of the HBV x gene mutation
Anita Artarini Aluicia
School of Pharmacy, Institut Teknologi Bandung, Indonesia

12:45 h – 13:00 h
Challenges in laboratory services in an Ethiopian hospital
Dr. Fantahun Biadglegne Degeneh
Bahir Dar University Hospital, College of Medicine and Health, Ethiopia

13:00 h – 13:15 h
T-cells and natural products in drug discovery
Dr. Amrita Nandan
CSIR-Institute of Genomics and Integrative Biology,New Delhi, India

13:15 h – 13:30 h
How marine biota enhance the efficacy of chemotherapeutic drugs in cancer
Agustina Nurcahyanti
Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia

14:00 h – 14:15 h
Medical and life science industry in search of young talents
Dr. rer. nat. Peter Quick
Promega GmbH, Mannheim

14:15 h – 14:30 h
The young scientists' view
Dr. rer. nat. Ronald Biemann
Institut für Klinische Chemie und Pathobiochemie, Universität Magdeburg

14:30 h – 14:45 h
Research and development in a diagnostic company
Prof. Dr. Matthias Grimmler
DiaSys Diagnostic Systems GmbH, Holzheim

14:45 h – 15:00 h
Compatibility aspects of career and family
Susanne Huber
Promega GmbH, Mannheim

15:00 h – 15:30 h
Round-table discussion
Holdenrieder, Quick, Biemann, Grimmler, Huber   


[Version: 09 November 2018, subject to changes]